Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (321-330 of 1,137) with videos related to

Pageof 114
Sort By:
Journal of the American College of Cardiology|August 26, 2017
Reply: Ezetimibe, Risk Stratification, and Secondary PreventionErin A Bohula, David A Morrow, Robert P Giugliano, et al.
Journal of Shoulder and Elbow Surgery|February 3, 2009
Functional outcome following endoprosthetic reconstruction of the proximal humerusChristopher P Cannon, Giovanni U Paraliticci, Patrick P Lin, et al.
Current Opinion in Immunology|August 21, 2007
Alternative mechanisms of immune receptor diversityGary W Litman, Larry J Dishaw, John P Cannon, et al.
Orthopedics|March 19, 2009
Proximal femoral endoprosthesis for the treatment of metastaticChristopher P Cannon, Attiqa N Mirza, Patrick P Lin, et al.
Alimentary Pharmacology & Therapeutics|July 15, 2009
Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelinesL Laine, L Connors, M R Griffin, et al.
Archives of Drug Information|February 17, 2010
A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and PlaceboChristopher P Cannon, Cong Chen, Sean P Curtis, et al.
Plant Disease|February 14, 2019
First Report of Armillaria Root Disease Caused by Armillaria tabescens on Araucaria araucana in Veracruz, MexicoM-S Kim, N B Klopfenstein, J W Hanna, et al.
Critical Pathways in Cardiology|November 18, 2011
Take heart: a one-on-one peer-based strategy to improve acute coronary syndrome patient careStephanie A Stowell, Christopher P Cannon, James W Hoekstra, et al.
International Journal of Clinical Practice|April 2, 2009
Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trialS Husted, R A Harrington, C P Cannon, et al.
Clinical Orthopaedics and Related Research|November 6, 2003
Endoprosthetic reconstructions for bone metastasesJeffrey J Eckardt, J Michael Kabo, Cynthia M Kelly, et al.
Pageof 114

Showing results (321-330 of 1,137) with videos related to

Sort By:
Pageof 114
Journal of the American College of Cardiology|August 26, 2017
Reply: Ezetimibe, Risk Stratification, and Secondary PreventionErin A Bohula, David A Morrow, Robert P Giugliano, et al.
Journal of Shoulder and Elbow Surgery|February 3, 2009
Functional outcome following endoprosthetic reconstruction of the proximal humerusChristopher P Cannon, Giovanni U Paraliticci, Patrick P Lin, et al.
Current Opinion in Immunology|August 21, 2007
Alternative mechanisms of immune receptor diversityGary W Litman, Larry J Dishaw, John P Cannon, et al.
Orthopedics|March 19, 2009
Proximal femoral endoprosthesis for the treatment of metastaticChristopher P Cannon, Attiqa N Mirza, Patrick P Lin, et al.
Alimentary Pharmacology & Therapeutics|July 15, 2009
Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelinesL Laine, L Connors, M R Griffin, et al.
Archives of Drug Information|February 17, 2010
A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and PlaceboChristopher P Cannon, Cong Chen, Sean P Curtis, et al.
Plant Disease|February 14, 2019
First Report of Armillaria Root Disease Caused by Armillaria tabescens on Araucaria araucana in Veracruz, MexicoM-S Kim, N B Klopfenstein, J W Hanna, et al.
Critical Pathways in Cardiology|November 18, 2011
Take heart: a one-on-one peer-based strategy to improve acute coronary syndrome patient careStephanie A Stowell, Christopher P Cannon, James W Hoekstra, et al.
International Journal of Clinical Practice|April 2, 2009
Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trialS Husted, R A Harrington, C P Cannon, et al.
Clinical Orthopaedics and Related Research|November 6, 2003
Endoprosthetic reconstructions for bone metastasesJeffrey J Eckardt, J Michael Kabo, Cynthia M Kelly, et al.
Pageof 114